DraftKings slips as NCAA trademark lawsuit adds legal overhang during tournament season

DraftKings Inc. (DKNG) is down 5.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The most visible near-term catalyst appears to be renewed investor focus on legal and regulatory headline risk after the NCAA moved to block DraftKings’ use of tournament-related trademarks. With March tournament betting activity at a peak, the prospect of an injunction or a drawn-out dispute can create uncertainty around marketing language, promotions, and reputational risk.

Details:

The NCAA filed a federal trademark complaint seeking emergency relief to stop DraftKings from using terms tied to the men’s and women’s basketball tournaments, including “March Madness,” “Final Four,” “Elite Eight,” and “Sweet Sixteen,” or similar variations.

The requested court action includes a temporary restraining order aimed at preventing the alleged use in DraftKings’ sportsbook products, promotional campaigns, and marketing materials.

DraftKings responded that it is not using “March Madness” as a trademark and characterized its usage as fair use and protected speech, indicating it plans to fight the request for an injunction.

Separate from this specific dispute, DraftKings’ SEC disclosures describe ongoing legal proceedings as part of its normal course of business, which can amplify sensitivity to fresh litigation headlines when the stock is already volatile.

Sources:

Associated Press, U.S. Securities and Exchange Commission, DraftKings Investor Relations

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$DKNG Insider Trading Activity

$DKNG insiders have traded $DKNG stock on the open market 17 times in the past 6 months. Of those trades, 3 have been purchases and 14 have been sales.

Here’s a breakdown of recent trading of $DKNG stock by insiders over the last 6 months:

PAUL LIBERMAN (See Remarks) has made 0 purchases and 2 sales selling 484,417 shares for an estimated $12,187,931.
R STANTON DODGE (Chief Legal Officer) has made 0 purchases and 7 sales selling 211,108 shares for an estimated $6,830,296.
HARRY SLOAN has made 2 purchases buying 125,000 shares for an estimated $2,942,500 and 0 sales.
GREGORY WESTIN WENDT purchased 10,000 shares for an estimated $302,700
ALAN WAYNE ELLINGSON (Chief Financial Officer) sold 8,421 shares for an estimated $246,145
ERIK BRADBURY (Chief Accounting Officer) has made 0 purchases and 3 sales selling 10,151 shares for an estimated $234,330.
JOCELYN MOORE sold 2,150 shares for an estimated $55,040

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$DKNG Hedge Fund Activity

We have seen 366 institutional investors add shares of $DKNG stock to their portfolio, and 542 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

WELLINGTON MANAGEMENT GROUP LLP removed 19,061,893 shares (-97.5%) from their portfolio in Q4 2025, for an estimated $656,872,832
CAPITAL WORLD INVESTORS added 12,008,357 shares (+181.4%) to their portfolio in Q4 2025, for an estimated $413,807,982
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 11,442,563 shares (-60.7%) from their portfolio in Q4 2025, for an estimated $394,310,720
CITADEL ADVISORS LLC added 9,295,010 shares (+862.7%) to their portfolio in Q4 2025, for an estimated $320,306,044
JANUS HENDERSON GROUP PLC added 8,524,923 shares (+50.8%) to their portfolio in Q4 2025, for an estimated $293,768,846
WHALE ROCK CAPITAL MANAGEMENT LLC removed 5,339,131 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $199,683,499
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 5,092,548 shares (-74.6%) from their portfolio in Q4 2025, for an estimated $175,489,204

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$DKNG Analyst Ratings

Wall Street analysts have issued reports on $DKNG in the last several months. We have seen 19 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

Stifel issued a "Buy" rating on 01/30/2026
Wells Fargo issued a "Overweight" rating on 01/15/2026
Needham issued a "Buy" rating on 11/19/2025
Mizuho issued a "Outperform" rating on 11/13/2025
Truist Securities issued a "Buy" rating on 11/10/2025
Bernstein issued a "Outperform" rating on 11/10/2025
Susquehanna issued a "Positive" rating on 11/10/2025

To track analyst ratings and price targets for $DKNG, check out Quiver Quantitative's $DKNG forecast page.

$DKNG Price Targets

Multiple analysts have issued price targets for $DKNG recently. We have seen 28 analysts offer price targets for $DKNG in the last 6 months, with a median target of $40.0.

Here are some recent targets:

Clark Lampen from BTIG set a target price of $35.0 on 03/23/2026
Robin Farley from UBS set a target price of $43.0 on 03/16/2026
Chad Beynon from Macquarie set a target price of $40.0 on 03/03/2026
Brian Pitz from BMO Capital set a target price of $50.0 on 03/03/2026
Jordan Bender from Citizens set a target price of $38.0 on 03/03/2026
Bernie McTernan from Needham set a target price of $35.0 on 03/03/2026
Ed Young from Morgan Stanley set a target price of $40.0 on 02/24/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.